Showing results (251-260 of 4,126) with videos related to

Sort By:
Pageof 413
Journal of Cancer Research and Clinical Oncology|March 16, 2022
Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancerXuan Wang, Keying Che, Tao Shi, et al.
Journal of Translational Medicine|September 23, 2021
FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinomaYue Wang, Tao Shi, Xuan Wang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 5, 2010
Enhanced cytotoxicity and activation of ROS-dependent c-Jun NH2-terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in Lovo cells--a possible Trojan strategy against cancerXiaolin Li, Donghui Zhen, Xiaowei Lu, et al.
Oncotargets and Therapy|February 12, 2021
Combination Therapy with iRGD-antiCD3 and PD-1 Blockade Enhances Antitumor Potency of Cord Blood-Derived T CellsMei Zhu, Hongmei Wang, Shujuan Zhou, et al.
Human Vaccines & Immunotherapeutics|August 5, 2024
Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activationJie Shao, Kai Xin, Zhaoye Qian, et al.
Plos One|January 18, 2013
BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapyYong Gao, Jing Zhu, Xiaohui Zhang, et al.
Plos One|June 14, 2013
Synergistic anticancer effects of polyphyllin I and evodiamine on freshly-removed human gastric tumorsGuofeng Yue, Jia Wei, Xiaoping Qian, et al.
Frontiers in Oncology|December 12, 2022
Case Report: Small intestinal metastatic breast cancer: A case report and literature reviewYishan Li, Lianru Zhang, Huiping Yu, et al.
Frontiers in Immunology|March 19, 2024
Case report: A case of advanced gastric cancer with multiple skin metastases, with significant relief from immunotherapyWen Hao, Ruimin Chang, Jingxin Liu, et al.
Cancer Medicine|November 6, 2023
Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective studyJingyi Guo, Qun Zhou, Mingzhen Zhou, et al.
Pageof 413